Date
Sun, September 8
Time
1:03am EDT
Location
On-Demand

On-Demand Webinar: Elevate and De-Risk Your Drug Portfolio Strategy With AI

Data-driven insights and AI can reduce clinical development risk and improve quantitative rigor in portfolio strategy. Panelists will share how they’ve used AI and insights tools to validate and calibrate the probability of technical and regulatory success (PTRS), support asset prioritization, and inform pipeline performance and strategic decisions about asset development.

Key Learning Objectives

  • Learn how to increase R&D ROI, accelerate time-to-market, and inform smarter investments using AI-driven PTRS assessments.     
  • Identify indications that present the best chances for certain types of assets to succeed using the latest clinical developments.
  • Target methods to help reduce inherent biases by incorporating quantitative rigor into decision-making.